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ABSTRACT
Developmental defects affecting the heart and aortic arch arteries are
a significant phenotype observed in individuals with 22q11 deletion
syndrome and are caused by amicrodeletion on chromosome 22q11.
TBX1, one of the deleted genes, is expressed throughout the
pharyngeal arches and is considered a key gene, when mutated, for
the arch artery defects. Pax9 is expressed in the pharyngeal
endoderm and is downregulated in Tbx1 mutant mice. We show
here that Pax9-deficient mice are born with complex cardiovascular
malformations that affect the outflow tract and aortic arch arteries with
failure of the 3rd and 4th pharyngeal arch arteries to form correctly.
Transcriptome analysis indicated that Pax9 and Tbx1 may function
together, and mice double heterozygous for Tbx1/Pax9 presented
with a significantly increased incidence of interrupted aortic arch
when compared with Tbx1 heterozygous mice. Using a novel
Pax9Cre allele, we demonstrated that the site of this Tbx1-Pax9
genetic interaction is the pharyngeal endoderm, therefore revealing
that a Tbx1-Pax9-controlled signalling mechanism emanating from
the pharyngeal endoderm is required for crucial tissue interactions
during normal morphogenesis of the pharyngeal arch artery system.
KEY WORDS: Pharyngeal endoderm, Arch artery development,
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INTRODUCTION
Conotruncal heart malformations, which affect the outflow tract and
aortic arch arteries, occur in 30% of all cases of congenital heart
defects (Thom et al., 2006). Approximately 20% of foetuses
identified with conotruncal defects by ultrasound are diagnosed
with 22q11 deletion syndrome (22q11DS) (Boudjemline et al.,
2001), the most commonmicrodeletion syndromewith an incidence
of 1:4000 live births (Scambler, 2000). Patients typically have a
3 Mb deletion on chromosome 22 that encompasses 45 protein-
coding genes (Morrow et al., 2018) and ∼80% of patients present
with some form of congenital cardiovascular defect (Momma,
2010), of which one of the most common observed is interruption of
the aortic arch (IAA) (Unolt et al., 2018). Although clinically rare in
the general population,∼50% of all cases of IAA occur in 22q11DS
patients (Boudjemline et al., 2001; Lewin et al., 1997; Van Mierop
and Kutsche, 1986). IAA is a consequence of the left 4th pharyngeal
arch artery (PAA) failing to form correctly during embryonic
development. There are five pairs of PAAs that arise within a series
of repeated protuberances on either side of the developing pharynx
known as the pharyngeal arches. These arches consist of paraxial
mesoderm- and neural crest cell (NCC)-derived mesenchyme, and
are externally enclosed by ectoderm and internally lined by
endoderm (Graham, 2003). The initially bilaterally symmetrical
PAAs develop sequentially in a cranial to caudal sequence during
embryogenesis but undergo a complex remodelling process, which
is conserved in mammals, to form the asymmetrical mature aortic
arch configuration (Bamforth et al., 2013; Hiruma et al., 2002). Of
the genes deleted in 22q11DS, hemizygosity of TBX1 is considered
to be the cause of the cardiovascular defects, with point mutations in
TBX1 also identified in individuals with 22q11DS-like phenotypes
(Yagi et al., 2003; Zweier et al., 2007). Tbx1 is expressed
throughout the pharyngeal arches within the ectoderm, endoderm
and mesoderm cells, and is crucial for pharyngeal arch and PAA
development (Jerome and Papaioannou, 2001; Lindsay et al., 2001;
Merscher et al., 2001). Complete loss of Tbx1 from the mouse
results in a failure of the pharyngeal arches to form correctly,
resulting in hypoplasia of the second arch and aplasia of the
remaining caudal arches, leading to an absent thymus and common
arterial trunk (Jerome and Papaioannou, 2001; Merscher et al.,
2001). In contrast, heterozygous deletion of Tbx1 predominantly
affects development of the 4th PAA resulting in IAA in a minority
of mice with aberrant right-subclavian artery (A-RSA) observed
more frequently (Lindsay et al., 2001). Tbx1 heterozygotes may,
however, also present with VSD, overriding aorta, double aortic
arch and an abnormal thymus (Merscher et al., 2001; Zhang
and Baldini, 2008). Although almost all 22q11DS patients areReceived 13 March 2019; Accepted 14 August 2019
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hemizygous for the deletion, the phenotypic spectrum is highly
variable (Unolt et al., 2018); thus, it has been proposed that genes
outside of the deleted region may impact on the clinical phenotype
(Guo et al., 2011b). Several genes have been identified as potential
modifiers of 22q11DS, as determined by genetic interaction studies
and transcriptome analyses in Tbx1 mutant mice (Aggarwal and
Morrow, 2008; Ivins et al., 2005; Liao et al., 2008; Papangeli and
Scambler, 2013). One such candidate gene is Pax9 the expression of
which in the pharyngeal endoderm was found to be significantly
reduced in Tbx1-deficient embryos (Ivins et al., 2005; Liao et al.,
2008). Pax9 belongs to a family of Pax genes encoding transcription
factors involved in various cellular roles during embryonic
development (Chi and Epstein, 2002; Mansouri et al., 1996) and
is specifically expressed in the endoderm of all four pharyngeal
pouches of the mouse by E9.5 (Neubüser et al., 1995). At later
stages in mouse development, Pax9 is expressed in the oesophagus,
somites and limbs, and within the neural crest contributing to
craniofacial development (Peters et al., 1998). Embryos deficient
for Pax9 exhibit craniofacial defects, including a cleft secondary
palate as well as absent teeth, skeletal defects and lack derivatives of
the 3rd and 4th pharyngeal pouches, i.e. the thymus, parathyroids
and ultimobranchial bodies (Peters et al., 1998), yet the role of Pax9
in cardiovascular development has not been determined.
In this study, we have investigated cardiovascular development in
Pax9-deficient mice, and show that loss of Pax9 leads to complex
cardiovascular defects affecting the outflow tract and aortic arch
arteries. We also uncover a strong genetic interaction between Tbx1
and Pax9 that leads to 4th PAA-derived defects in double
heterozygous mice; this interaction is cell-autonomous within the
pharyngeal endoderm.
RESULTS
Pax9-deficient embryos have cardiovascular defects
Mice lacking Pax9 die perinatally and exhibit craniofacial,
pharyngeal gland and skeletal defects (Peters et al., 1998). As the
cause of death was unclear, we carefully re-analysed Pax9–/–
neonates from a Pax9+/– intercross and found that all Pax9–/–
neonates had a patterning defect of their aortic arch arteries that
included an IAA with A-RSA (Fig. 1B; Table 1). To investigate
these defects in more detail, we processed Pax9–/– embryos for
histology and magnetic resonance imaging (MRI), and found that
Pax9–/– embryos presented with a wide range of cardiovascular
abnormalities (Fig. 1C-Q; Table 1). These defects included double
outlet right ventricle with interventricular communication (Fig. 1F,
J,K), IAA and A-RSA (Fig. 1G,K). The common carotid arteries
were also frequently absent, resulting in unilateral or bilateral
internal and external carotids arising directly from the dorsal aorta
and the A-RSA (Fig. 1H,J-L). Pax9–/– embryos also had a
hypoplastic aorta (Fig. 1N-O) and bicuspid aortic valves (Fig. 1Q).
Developmental defects of the arch arteries occur when the PAAs
fail to form or remodel correctly. To investigate the morphogenesis
of the PAAs, we performed high-resolution episcopic microscopy
(HREM) on E10.5 and E11.5 Pax9–/– embryos and manually
segmented the datasets to create 3D images of the PAA. Embryos
were stage-matched by somite counting to exclude developmental
delay as a cause of observed defects. Analysis of E10.5 coronal
sections revealed that the 3rd and 4th pharyngeal arches of Pax9–/–
embryos were smaller compared with Pax9+/+ controls, as
previously reported (Peters et al., 1998), but did show
segmentation to individual arches (Fig. 2A-C). At E10.5, the
developing PAAs are bilaterally symmetrical, having formed in a
cranial to caudal sequence. The 1st and 2nd PAAs have normally
regressed by this stage, and the 3rd, 4th and 6th PAAs are present
(Bamforth et al., 2013; Hiruma et al., 2002) (Fig. 2A). In Pax9–/–
embryos, the 1st and 2nd PAAs were abnormally persistent, the 3rd
PAAs were either absent, hypoplastic or interrupted, and the 4th
PAAs were absent (Fig. 2B,C; Table 2). The aortic sac was also
hypoplastic in Pax9–/– embryos compared with the controls
(Fig. 2B,C). Intra-cardiac injection of India ink at E10.5-E11.0
showed that, in controls, the caudal PAAs were patent to ink and of
equivalent size (Fig. 2D). In Pax9–/– embryos, however, persisting
1st and 2nd PAAs were patent to ink, and the 3rd PAAs were
hypoplastic (Fig. 2J-L) or non-patent to ink, and therefore presumed
absent. The majority of the 4th PAAs were bilaterally non-patent to
ink (Fig. 2J-L; Table 2). Immunohistochemical staining for Pecam1
showed that the endothelium within the 3rd and 4th pharyngeal
arches had formed lumenised PAAs at E10.5 in control embryos
(Fig. 2G), but in Pax9–/– embryos the 3rd PAAs were visibly smaller
in size and only isolated endothelial cells were seen within the 4th
pharyngeal arch (Fig. 2H,I).
During E11.5 of mouse development, the PAA system begins to
remodel and becomes asymmetric in appearance (Bamforth et al.,
2013; Hiruma et al., 2002). In Pax9 control embryos at this stage,
the right 6th PAAs appeared thinner and the distal outflow tract was
septated. The carotid duct, the region of the dorsal aorta between the
3rd and 4th PAAs, had begun to involute, but the 3rd, 4th and 6th
PAAs remained connected to the dorsal aortae (Fig. 3A). In Pax9–/–
embryos at E11.5, presumed persisting 1st or 2nd PAAs were
observed extending anteriorly from the aortic sac, and the 3rd PAAs
were also affected, either unilaterally or bilaterally, being either
absent, hypoplastic or interrupted and not connected to the dorsal
aortae (Fig. 3B-D). The carotid ducts were maintained, and this,
coupled with the abnormal detachment of the 3rd PAAs from the
dorsal aorta and the persistence of the 1st or 2nd PAAs, resulted in
an absent common carotid artery and the internal and external
carotid arteries arising directly from the aortic arch arteries, as
observed at E15.5 (Fig. 1). Additionally, the distal outflow tract was
unseptated and the 4th PAAs were bilaterally absent (Fig. 3B-D;
Table 2).
Looping of the heart tube at E10.5 was not affected in Pax9–/–
embryos (Fig. 3E,F).
In normal mouse development, the outflow tract cushions rotate
through an anticlockwise direction (Bajolle et al., 2006), resulting in
the major septal and parietal cushions being positioned side by side
(Fig. 3G-I). In Pax9–/– embryos, however, by the end of the E11.5
stage these cushions were aberrantly positioned, with the parietal
cushion more anterior to the septal cushion, indicating that a
clockwise rotation of the outflow tract cushions had occurred
(Fig. 3J-L).
Pharyngeal endoderm signalling influences neural crest cell
differentiation
During normal embryogenesis, a subset of NCCs, the cardiac neural
crest cells, migrate into the caudal pharyngeal arches to provide
support to the developing PAAs and also contribute to outflow tract
septation (Hutson and Kirby, 2003). Pax9 is predominantly
expressed in the pharyngeal endoderm (Fig. S1), but is also
known to be expressed within the NCC and contributes to
craniofacial development (Kist et al., 2007), although expression
in cardiac NCC has not been described. We therefore looked to see
whether a cell-autonomous loss of Pax9 from NCC resulted in
cardiovascular defects. Conditional deletion of Pax9 usingWnt1Cre
transgenic mice (Danielian et al., 1998), and the Pax9flox allele (Kist
et al., 2007), however, did not result in cardiovascular abnormalities,
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although cleft palate was observed as expected (Fig. 4A-D). We next
looked to see whether the migration of NCCs was affected in global
Pax9–/– embryos using Wnt1Cre and eYFP (Srinivas et al., 2001)
reporter mice to create embryos where the NCC could be lineage
traced. Live fluorescence imaging of Pax9+/+;Wnt1Cre;eYFP
embryos at E9.5 and E10.5 revealed NCCs present in the head
and dorsal root ganglia, as well as migrating towards and filling the
pharyngeal arches (Fig. 4E,G). A similar pattern was observed in
Pax9–/–;Wnt1Cre;eYFP embryos (Fig. 4F,H). Counting of NCCs
revealed no significant change in their number in the 3rd pharyngeal
arch at E9.5, but a significant reduction was found in the 3rd and 4th
arches at E10.5 (Fig. 4K). Immunostaining for BrdU incorporation
specifically in NCCs showed no significant difference in NCC
proliferation in the caudal pharyngeal arches (Fig. 4L-N), and very
little apoptosis was seen in both control and Pax9–/– embryos
(Fig. 4O-Q). These observations indicated that the migration of
NCCs per se to the pharyngeal arches was not affected in Pax9–/–
embryos. Given that NCCs differentiate into the smooth muscle
Fig. 1. Loss of Pax9 results in cardiovascular developmental defects. (A) Arch arteries of control neonates were normal (n=8). (B) Pax9–/–
neonates (n=5) displayed IAA-B, absent right subclavian artery (presumed retro-oesophageal), and atypical right and left carotid arteries (LC and RC).
Scale bars: 1 mm. (C-E) Pax9+/+ embryos at E14.5 show normal outflow tract, arch arteries and thymus. (F-H) In Pax9–/–embryos (n=4), the aorta (Ao) arises
aberrantly from the right ventricle producing a double outlet right ventricle (DORV; F). Hypoplastic aorta, IAA-B and an A-RSA are present (G). More cranially,
the thymus is absent and aberrant internal and external carotid arteries (iRCA, eRCA, iLCA, eLCA) are seen (H). (I-L) 3D reconstructions of E15.5 hearts
from MRI datasets. (I) Pax9+/+ embryo with normal aortic arch arteries. (J-L) In Pax9–/–embryos (n=15), defects seen are DORV with interventricular
communication (IVC), IAA (type B or C), A-RSA (retro-esophageal in J,K and isolated in L) and aberrant carotid arteries. Scale bars: 500 μm. (M-O) The
ascending aorta is significantly smaller in Pax9–/– embryos (n=5) compared with Pax9+/– control embryos (n=7). Data are mean±s.e.m. ****P<0.0001
(two-tailed unpaired t-test). (P) Pax9+/– control embryos have three normal aortic valve leaflets (n=6): the right (RC), left (LC) and non-coronary (NC). (Q) Pax9–/–
embryos (n=5) have bicuspid aortic valve (BAV). Scale bar: 100 μm. AoA, aortic arch; AD, arterial duct; BC, brachiocephalic; dAo, dorsal aorta; LCC,
left common carotid artery; LSA, left subclavian artery; LV, left ventricle; RCC, right common carotid artery; RSA, right subclavian artery; RV, right ventricle.
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cells (SMCs) that support the remodelling PAAs (Waldo et al.,
1996), we looked to see whether SMC recruitment to the 3rd PAAs
was affected in Pax9–/– embryos. Sections from E10.5 and E11.5
embryos were immunostained using an anti-alpha smooth muscle
actin antibody to visualise SMCs around the PAAs. Evidence of
SMC recruitment to the 3rd PAAs was seen in each control embryo
examined (Fig. 4R-U); however, very little SMC recruitment to the
3rd PAAs in Pax9–/– embryo sections was observed (Fig. 4V-Y).
These results indicate that the 3rd PAAs in Pax9–/– embryos form
but collapse from a failure of SMC recruitment.
Tbx1 and Pax9 interact in 4th PAA formation
To further investigate the role ofPax9 in cardiovascular development,
we looked at the effect of Pax9 loss on the pharyngeal arch
transcriptome at E9.5 (Fig. 5A-C). Analysis of the RNA-seq data
identified 3863 significant differentially expressed genes (Table S1).
Table 1. Number of cardiovascular defects observed in mutant embryos (>E13.5) and neonates
Genotype Stage n VSD DORV+IVC IAA‡ IAA+A-RSA§ A-RSA§ Vascular ring¶ Cervical AoA+A-RSA Absent CC‡‡
Pax9–/– Neonatal 5 NA NA 0 5 (100%) 0 0 0 2 (40%)
E14.5-E15.5 19 3 (16%) 15 (79%) 3 (16%) 14 (74%) 2 (11%) 0 0 15 (79%)
Tbx1+/– Neonatal 6 NA NA 0 1 (17%) 3 (50%) 0 0 0
Tbx1+/–; Pax9+/– 9 1 (11%) 5 (55%) 2 (22%) 0 1 (11%) 0
Tbx1+/– E15.5 19 0 0 0 1 (5%) 9 (47%) 0 2 (11%) 0
Tbx1+/–; Pax9+/– 20 6* (30%) 0 0 14** (70%) 3 (15%) 0 3 (15%) 0
Tbx1+/flox; Pax9Cre Neonatal 8 0 0 0 0 4 (50%) 1 (12.5%) 0 0
E13.5-E15.5 26 0 0 0 1 (4%) 6 (23%) 3 (11.5%) 0 0
Pax9–/– neonates (n=5) were analysed by dissection, embryos at E14.5 by histology (n=4) and at E15.5 byMRI (n=15). Tbx1+/– (n=19) and Tbx1+/–;Pax9+/– (n=20)
embryos were analysed by MRI. Tbx1+/flox;Pax9Cre embryos were analysed by MRI (n=17) and µCT (n=9). All wild-type (n=16), Pax9+/– (n=15) and Tbx1+/flox
(n=5) control embryos assessed were normal. There was a statistically significant increase in the incidence of VSD and IAA in the Tbx1+/–;Pax9+/– embryos
compared with the Tbx1+/– embryos. *P<0.05, **P<0.0001 (Pearson’s chi-squared test for associations).
‡Combined incidence of IAA, irrespective of co-occurrencewith A-RSA, inPax9–/– neonates and embryos (n=24) was 92% (n=19 type-B and n=3 type-C). In Tbx1
mutants, IAA was always type B.
§A-RSA refers to a retro-oesophageal, cervical origin or isolated right subclavian artery. Two Pax9–/– embryos had isolated RSA.
¶Vascular ring is used to describe a right-sided aorta with A-RSA.
‡‡Absent common carotid artery (CC), resulting in the internal and external carotid arteries arising directly from the main aortic vessels, unilaterally (n=4) or
bilaterally (n=11) in Pax9–/– embryos.
AoA, aortic arch; DORV+IVC, double outlet right ventricle with interventricular communication; VSD, perimembranous ventricular septal defect; NA, not
assessed.
Fig. 2. Pax9 loss causes aberrations in pharyngeal
arch artery formation. (A-C) Coronal views of control
(Pax9+/+) and mutant (Pax9–/–) embryos at E10.5 (30-
40 s), examined by high-resolution episcopic microscopy.
(A) In Pax9+/+ control embryos (n=5), the 3rd, 4th and 6th
PAAs are of equal size and bilaterally symmetrical. (B,C) In
Pax9–/– embryos (n=4), the 4th PAAs were bilaterally
absent (asterisk), the 3rd PAAs and aortic sac (as) were
hypoplastic, and the 1st and/or 2nd PAAs abnormally
persisted. (D-F) Intracardiac ink injection into E10.5-E11.0
(31-42 s) embryos. (D) In control embryos (n=12), PAAs
3-6 are patent to ink, are of equivalent diameter and are
bilaterally symmetrical. (E,F) In Pax9–/– embryos (n=12),
the 3rd PAAs are hypoplastic and the 4th PAAs are
non-patent to ink (asterisk). (F) The 1st and 2nd PAAs are
persisting anomalously. (G-I) Immunostaining using
anti-Pecam1 antibody at E10.5 (31-36 s). (G) Control
embryos (n=3) have a ring of Pecam1-positive endothelium
lining the 3rd and 4th PAAs. (H,I) InPax9–/– embryos (n=5),
the 3rd PAAs are visibly smaller and disorganized
endothelial cells are within the 4th pharyngeal arch (pa;
arrows). Somite counts (s) are indicated. Scale bars:
100 μm. The somite numbers given in the legend reflect the
range analysed for the whole study. The figure contains
representative images only.
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Gene set enrichment analysis revealed several significantly
downregulated pathways, including ‘extracellular matrix
organisation’ and ‘axon guidance’ (Fig. 5D). Interestingly, Tbx1
was significantly reduced in Pax9–/– embryos at E9.5, and this was
confirmed by qPCR (Fig. 5I). We also confirmed that Pax9
expression was reduced in Tbx1-null embryos (Fig. S2). As Tbx1
expression is crucial for 4th PAA morphogenesis (Lindsay et al.,
2001; Zhang et al., 2005), these data suggested that Pax9 may
function together with Tbx1 rather than being downstream of it. We
therefore compiled a list of all the genes reported to be significantly
Table 2. Number of pharyngeal arch artery defects
Genotype n PAA Abnormal (%) Unilateral defect Bilateral defect
Bilateral defects
Present Hypo/Int/Abs Absent
Pax9−/– 20 1 11 (55%) 1 10 9 1 0
2 8 (40%) 3 5 4 1 0
3 15 (75%) 3 12 - 8 4
4 20 (100%) 1 19 - 3 16
Tbx1+/– 8 4 8 (100%) 4 4 - 4 0
Tbx1+/–; Pax9+/– 9 4 9 (100%) 1 8 - 1 7*
Tbx1+/flox 15 4 0 0 0 - 0 0
Tbx1+/flox; Pax9Cre 17 4 16 (92%) 3 13 - 7 6
Embryos were collected and assessed for PAA defects. Pax9–/– embryos were either injected intracardially with ink (E10.5; n=12) or imaged using HREM (E10.5-
E11.5; n=8) to visualise the PAA. Data are combined. For Pax9–/– embryos, each left and right PAA 1-4 was scored as having a unilateral or bilateral defect, and the
bilateral defects categorised as either present, a combination of hypoplastic, interrupted and/or absent (Hypo/Int/Abs), and bilaterally absent. For Tbx1;Pax9
genotypes, ink injection was performed at E10.5 and only the 4th PAAwas scored. The increase in bilaterally absent 4th PAA inTbx1+/–;Pax9+/– embryos is significant
compared with Tbx1+/– embryos. *P=0.004 (Pearson’s chi-squared test for associations). All control Pax9+/+ (n=18) and Pax9+/– (n=25) embryos were normal.
Fig. 3. Pax9–/– embryos display aberrant rotation of the outflow tract and abnormal PAA remodelling. Image datasets were acquired by high-resolution
episcopic microscopy. (A-D) 3D reconstructions of the PAAs at E11.5 (45-50 s). (A) In Pax9+/+ control embryos (n=5), the outflow tract is septated, the right 6th
PAA has thinned and the carotid duct (cd) has begun to involute. (B-D) In Pax9–/– embryos (n=4), the 4th PAAs are absent and the 3rd PAAs are aberrantly
connected or detached from the dorsal aorta (da; asterisks). The carotid duct has failed to involute and septation of the outflow tract is delayed. Persisting
1st or 2nd PAAs are observed coursing anteriorly from the abnormal 3rd PAAs (B,D) or from the aortic sac (as; C). (E,F) Looping of the heart tube at E10.5 was not
affected in Pax9–/– embryos (n=4). (G-L) Outflow tract rotation from E10.5 to E11.5 (39-49 s). (G-I) In control embryos, the major outflow tract cushions
(parietal in green; septal in yellow) rotated in an anti-clockwise direction, resulting in the cushions being aligned side by side. (J-L) In Pax9–/– embryos, the
cushions rotated in a clockwise direction, resulting in the parietal cushion being anterior to the septal cushion. at, aortic trunk; pa, pulmonary arteries; pt,
pulmonary trunk. Somite (s) counts indicated. Scale bars: 100 μm.
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Fig. 4. Failure in smoothmuscle cell recruitment causes the 3rd PAAs to collapse. (A-D) E15.5 embryos with aPax9 conditional deletion in neural crest cells
(NCCs) were examined by MRI. (A) Control embryos had a normal palate (P). (B) Pax9f/f;Wnt1Cre mutant embryos (n=6) had cleft palate (CP). (C,D) No
cardiovascular defects were observed in control or mutant embryos. Ao, aorta; AD, arterial duct; LCC, left common carotid artery; LSA, left subclavian artery;
LV, left ventricle; RCC, right common carotid artery; RSA, right subclavian artery; RV, right ventricle. (E-J) NCCs in Pax9+/+ (E,G,I) or Pax9–/– (F,H,J)
embryos were labelled using Wnt1Cre and eYFP alleles. (E-H) Fluorescence imaging showed no difference in NCC migration into the pharyngeal arches
(arrowheads) at E9.5 (n≥3, 23-25 s) and E10.5 (n≥5, 32-36 s). (I,J) Fluorescent embryos were sectioned coronally and immunostained using anti-GFP and
anti-Pax9 antibodies. (K) NCCs were counted from immunostained sections. *P<0.05, ***P<0.001 (two-tailed unpaired t-test). (L,M) Embryo sections were
immunostained with anti-BrdU and anti-GFP antibodies to detect proliferation in NCCs in Pax9+/+ (L) and Pax9–/– (M) embryos. (N) No significant difference
in the rate of proliferation was found between control and Pax9–/– NCCs in the caudal arches at E9.5 (n=3, 23-28 s) or E10.5 (n≥4, 31-39 s). (O,P) Embryo
sections immunostained using an anti-caspase 3 antibody to detect apoptosis in the caudal pharyngeal arches of Pax9+/+ (N,O) and Pax9–/– (P) embryos. (Q) No
significant difference in the rate of apoptosis was found between control and Pax9–/– embryos at E9.5 (n=3, 24-28 s) or E10.5 (n=3, 30-35 s). Two-tailed
unpaired t-test. (R-Y) Embryo sections were immunostained using anti-αSMA antibody for smooth muscle (R,R″-U,V,V″-Y,S,W), anti-Pecam1 (R,R′,V,V′) or
-ERG (T,U,X,Y) antibodies for endothelium, or anti-GFP to label NCCs in Wnt1Cre;eYFP embryos (S,W). In all control embryos, SMC surrounded the 3rd
PAAs [E10.5, n=7, 31-36 s (R,S); and E11.5, n=3, 43-45 s (T,U); red arrowhead]. In Pax9–/– embryos, the 3rd PAAs had limited recruitment of SMCs [E10.5, n=6;
32-35 s (V,W); and E11.5, n=3, 42-45 s (X,Y); white arrowheads]. da, dorsal aorta; en, endoderm; mc, mesenchyme; ns, not significant; pa, pharyngeal arch.
Somite counts (s) are indicated. Scale bars: 500 μm in A-D; 100 μm in E-J,L,M,O,P; 50 µm in R-Y. The somite numbers given in the legend reflect the range
analysed for the whole study. The figure contains representative images only.
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Fig. 5. Pax9 shares a genetic network with Tbx1. (A) The pharyngeal arch region of control and Pax9–/– embryos at E9.5 (n=3 per genotype; 26-27 s) was
dissected (indicated by dashed lines). Scale bar: 500 µm. (B) Total RNA was extracted, converted to cDNA and checked by qPCR. (C) Principle component
analysis of RNA-seq data showed a clear separation between control and mutant samples (shown on PC2) and only slight biological variation across replicates
(shown on PC1). (D) Gene set enrichment analysis identified signalling pathways predicted to be significantly downregulated in Pax9–/– embryos. All pathways
shown have a familywise-error rate of P<0.001. (E) Tbx1-related genes (n=1476) were compared with those genes significantly differentially expressed (DE) in
Pax9–/– embryo tissue (n=3863, adjusted P≤0.1) giving 342 genes common to both datasets (*P=0.0029, as assessed by a hypergeometric distribution test).
Examples of genes in each cohort are shown. (F) Volcano plot highlighting Tbx1-interacting genes significantly DE in Pax9–/– embryos (based on adjusted
P≤0.1). (G) Heat map showing colour-coded (red, up; blue, down) expression levels of DE genes between Pax9+/+ (wt) and Pax9–/– (mt) embryos that are
common to Tbx1 DE genes (adjusted P≤0.05 are shown). (H-K) qPCR analysis confirmed that Pax9 (H), Tbx1 (I), Chd7 (J) and Gbx2 (K) were significantly
reduced in Pax9–/– pharyngeal tissue at E9.5 (n=5 embryos per genotype). **P<0.01; two-tailed unpaired t-test (Tbx1 and Chd7) and two-tailed Mann–Whitney
(Pax9 andGbx2). (L-S) RNAscope in situ hybridisation showed a reduced expression of Pax9 (M), Tbx1 (O),Chd7 (Q) andGbx2 (S) in the pharyngeal endoderm
in Pax9–/– embryos at E9.5 (n=3 per genotype, 23-28 s). en, endoderm; me, mesoderm; pa, pharyngeal arch. Somite counts (s) are indicated. Scale bars: 50 µm.
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differentially expressed in Tbx1-null embryos from published
microarray (Ivins et al., 2005; Liao et al., 2008; van Bueren et al.,
2010) and mouse genetic interaction studies, giving 1476 unique
Tbx1-related genes. These were then compared with all genes
significantly changed in Pax9–/– embryo pharyngeal arch tissue,
giving 342 genes that were common to both datasets (Fig. 5E-G;
Fig. S3; Table S1) and suggesting that Tbx1 and Pax9 may share a
genetic network. Among these common genes were Chd7 and Gbx2,
which have been shown to interact with Tbx1 in mice (Calmont et al.,
2009; Randall et al., 2009), and were also reduced in Pax9-null tissue
by qPCR and in situ hybridisation (Fig. 5H-S).
To investigate a potential genetic interaction in vivo between
Tbx1 and Pax9, we confirmed that both genes were co-expressed in
the pharyngeal endoderm (Fig. 6A-G). We then crossed Tbx1+/–
mice (Jerome and Papaioannou, 2001) with Pax9+/– mice to create
Tbx1+/–;Pax9+/– double heterozygotes. Genotype analysis of 168
pups at weaning revealed that only two Tbx1+/–;Pax9+/– mice were
alive, a highly significant deviation from the 42 expected of each
genotype from this cross (P=1.4×10−12; Table S2). To identify the
timing of lethality, neonates were observed from the day of birth
with all Tbx1+/–;Pax9+/– mutants dying during the first 24 h.
Examination of neonatal aortic arch arteries revealed that all
controls were normal (Fig. 6H), while Tbx1+/– neonates frequently
presented with A-RSA (Fig. 6I; Table 1). All dead Tbx1+/–;Pax9+/–
neonates had 4th PAA-derived defects, including IAA (Fig. 6J,K;
Table 1).
Fig. 6. Tbx1;Pax9 double heterozygous embryos
have 4th PAA defects. Tbx1 and Pax9 expression in
the pharyngeal arches was examined at E9.5.
(A-D) RNAScope in situ hybridisation expression of
Tbx1 in the 2nd and 3rd pharyngeal arch (pa),
endoderm (en) and mesoderm (me; A), and Pax9
expression in the endoderm only (B). The signals
overlap in the endoderm (C, and higher power in C′).
(D) DAPI staining. (E-G) Immunostaining for Tbx1 and
Pax9 (E) demonstrates protein colocalisation within
cells of the pharyngeal endoderm. Single staining for
Tbx1 (F) and Pax9 (G) is shown. (H-K) Neonates from a
Tbx1+/– and Pax9+/– intercross were recovered and the
aortic arches examined. (H) Arch arteries were normal in
all Pax9+/– neonates (n=10). (I) Tbx1+/– neonates (n=6)
often presented with A-RSA, inferred by the absence of
the brachiocephalic and right subclavian arteries.
(J,K) All Tbx1+/–; Pax9+/– neonates (n=9) died within
24 h of birth with IAA and/or A-RSA. (L-O) 3D
reconstructions of E15.5 embryo hearts from MRI
datasets. (L) Pax9+/– hearts were normal (n=15).
(M) Tbx1+/– hearts (n=19) frequently displayed 4th PAA
defects such as A-RSA. (N,O) All Tbx1+/–; Pax9+/–
embryos (n=20) presented with a 4th PAA-derived
defect such as IAA-B, A-RSA and/or cervical right
subclavian artery (cRSA). (P-S) Intracardiac ink
injections into E10.5 embryos (27-38 s). (P) PAAs in
control embryos were normal (n=10). (Q) In Tbx1+/–
embryos (n=8) the 4th PAAs were often hypoplastic.
(R,S) In Tbx1+/–;Pax9+/– embryos (n=9), the 4th PAAs
were frequently bilaterally absent. Ao, aorta; AoA, aortic
arch; AD, arterial duct; BC, brachiocephalic; LCC, left
common carotid artery; LSA, left subclavian artery; LV,
left ventricle; RCC, right common carotid artery; RSA,
right subclavian artery; RV, right ventricle. Somite
counts (s) are indicated. Scale bars: 2 mm in H-K;
500 μm in L-O; 100 μm in A-D,P-S; 50 µm in E-G.
(T-W) qPCR analysis in wild-type, Tbx1+/–, Pax9+/– and
Tbx1+/–;Pax9+/– embryos (n≥3 per genotype, somite
range 23-27). (T) Tbx1 levels were significantly reduced
in Tbx1+/– and Tbx1+/–;Pax9+/– embryos. (U)Pax9 levels
were significantly reduced in Pax9+/– and Tbx1+/–;
Pax9+/– embryos. There was no significant difference in
Tbx1 (T), Pax9 (U), Chd7 (V) or Gbx2 (W) levels
between single heterozygotes and Tbx1+/–;Pax9+/–
embryos. One-way ANOVA with Tukey’s multiple
comparison test. ns, not significant. *P<0.05, **P<0.01,
****P<0.0001.
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Having established postnatal cardiovascular defects, we next
analysed E15.5 Tbx1+/–;Pax9+/– embryos by MRI (Fig. 6L-O). All
wild-type and Pax9+/– embryos were normal. Of the Tbx1+/–
embryos examined, a high proportion had some form of 4th PAA-
derived defect, including IAA and A-RSA (Fig. 6M; Table 1). All
Tbx1+/–;Pax9+/– embryos examined, however, had some form of
4th PAA-derived defect (Fig. 6N,O; Table 1) with the incidence of
IAA being significantly increased compared with Tbx1+/– embryos
(P<0.001). The incidence of perimembranous VSD was also
significantly increased (P=0.04), but none of the embryos examined
displayed outflow tract defects or bicuspid aortic valve, although an
abnormal thymus was frequently observed (Fig. S4; Table S3).
Tbx1+/–;Pax9+/– embryos at E10.5 were injected intracardially with
ink (Fig. 6P-S) and the patency of the developing 4th PAAs was
then compared between Tbx1+/– and Tbx1+/–;Pax9+/– embryos
(Table 2). All Tbx1+/– embryos displayed a predominantly
hypoplastic 4th PAA defect, with 50% of embryos having a
unilateral, and 50% a bilateral, defect. In Tbx1+/–;Pax9+/– embryos,
a significant increase in bilateral aplasia of the 4th PAAs (P=0.004)
was found, but no defects of PAAs 1, 2, 3 or 6 were seen. RNA
analysis showed that Tbx1, Pax9, Chd7 and Gbx2 RNA levels were
not significantly changed between the respective single
heterozygotes and Tbx1+/–;Pax9+/– pharyngeal arches (Fig. 6T-W).
Tbx1 and Pax9 interact cell autonomously in the pharyngeal
endoderm for 4th PAA formation
The presumed site of the Tbx1-Pax9 interaction is the pharyngeal
endoderm, and to demonstrate a cell-autonomous interaction in this
tissue, we crossed Tbx1flox mice (Xu et al., 2004) with a novel
Pax9Cre transgenic mouse (Fig. 7A-C). This Pax9Cre strain has the
Cre recombinase gene inserted into the Pax9-coding region and
effectively results in a Pax9-null allele. The Pax9Cre allele
functions as expected by activating R26RlacZ expression
specifically in the pharyngeal endoderm from E9.5 to E11.5
(Fig. 7D-G; Fig. S5), and Pax9Cre;Pax9flox neonates (i.e. Pax9-
null) die at birth with the typical Pax9–/– phenotype (Fig. 7H-Q). To
test the specificity of the Pax9Cre allele, the pharyngeal arches of
Pax9Cre;eYFP E9.5 embryos (Fig. 8A) were dissociated into single
cells and flow-sorted into eYFP-positive and -negative populations.
The eYFP-positive population was significantly enriched for eYFP
and Pax9 transcripts (Fig. 8B,C). Tbx1flox and Pax9Cre mice were
intercrossed to create Tbx1+/ flox;Pax9Cre embryos, which are double
heterozygous for each gene but only in the Pax9 expression domain.
A significant reduction in Tbx1 RNA levels was observed in eYFP-
positive flow-sorted pharyngeal endoderm cells from conditionally
deletedE9.5mutant embryos comparedwithPax9Cre;eYFP controls
(Fig. 8D). Litters from a Tbx1+/flox and Pax9Cre cross were collected
on the day of birth; a significant reduction in the expected number of
Tbx1+/flox;Pax9Cremutants was found (P=2.4×10−5; Table S4) and
62.5% of these mutants displayed an arch artery defect (Fig. 8F;
Table 1). We then collected embryos (E13.5-E15.5) and analysed
them by MRI or µCT, which revealed that 38.5% of mutants
presented with an arch artery defect (Fig. 8H; Table 1) and an
abnormal thymus (Fig. S4; Table S3). We also collected embryos at
E10.5 and injected them intracardiallywith ink tovisualise the PAAs.
All Tbx1+/flox control embryos analysed had normal PAAs, with all
three vessels being patent to ink and of a similar diameter, while the
majority of Tbx1+/flox;Pax9Cremutant embryos presented with some
form of 4th PAA defect (Fig. 8J; Table 2).
In summary, our data show that Pax9 is crucial for cardiovascular
development, andwhen lost the PAAs and outflow tract fail to develop
correctly, resulting in postnatal death. The 4th PAAs do not form and
the 3rd PAAs collapse with reduced recruitment from vascular SMC.
Our data also demonstrate that Tbx1 and associated genes are
deregulated in Pax9-null embryos, and Tbx1 and Pax9 function
together in the pharyngeal endoderm for 4th PAA morphogenesis.
DISCUSSION
Loss of Pax9 results in complex cardiovascular defects
Pax9 plays a key role in cardiovascular development, as Pax9–/–
neonates and embryos display a range of cardiovascular defects.
Gene mutations and chromosomal deletions that include PAX9 have
been identified in individuals with cardiovascular abnormalities and
other conditions (Table S5), suggesting that PAX9 has potential
importance in human cardiovascular development. Of these, one
individual with a 105 kb hemizygous deletion of 14q13 presented
with IAA, a hypoplastic aorta, bicuspid aortic valve and a
ventricular septal defect (Santen et al., 2012), all of which
appear with high penetrance in mouse Pax9-null embryos. This
small deletion removed only PAX9, NKX2-1 and NKX2-8,
although deletion of either Nkx2 gene in mice does not result in
any cardiovascular defects (Kimura et al., 1996; Pabst et al.,
2003). It is therefore possible that hemizygous deletion of PAX9
in humans can recapitulate, in part, the mouse knockout
phenotype.
Tbx1 and Pax9 interact in 4th PAA development
Published microarray studies investigating the transcriptome
of Tbx1-null embryos have implicated Pax9 as a downstream
target of Tbx1 (Ivins et al., 2005; Liao et al., 2008). Further evidence
of crosstalk between Tbx1 and Pax9 has been suggested via the
interaction of Ripply3 (Okubo et al., 2011). This protein, which is a
Tbx1 repressor, has been shown to prevent Tbx1 activation of
luciferase from a Pax9 promoter construct, and Pax9 expression in
the pharyngeal endoderm is increased in Ripply3-null embryos
suggesting that Tbx1 may be upstream of Pax9. Ripply3 levels were
not significantly changed in our Pax9-null pharyngeal arch
transcriptome data, but Tbx1 levels were significantly reduced,
indicating that perhaps Pax9 and Tbx1 may function together rather
than work in a hierarchal pathway. This is further supported by
analysis of Tbx1 and Pax9RNA levels in Tbx1+/–;Pax9+/– embryos,
which were not significantly changed compared with levels seen in
the single heterozygotes. Further analysis identified that many genes
differentially expressed in Tbx1-null embryos, or shown to interact
with Tbx1 in mouse models, were also significantly differentially
expressed in Pax9-null embryos, e.g. Chd7 and Gbx2. Mice
heterozygous for Chd7 have abnormal 4th PAA derivatives and a
combined heterozygosity with Tbx1 results in an increased
incidence of 4th PAA defects (Randall et al., 2009). Gbx2-null
embryos display cardiovascular defects (Byrd and Meyers, 2005),
and Tbx1 and Gbx2 have also been shown to genetically interact in
PAA development (Calmont et al., 2009). Although both these
Tbx1 targets have been demonstrated to interact in the pharyngeal
ectoderm, they are also expressed in the pharyngeal endoderm and
could therefore interact with Pax9 either directly or indirectly in this
tissue. As our data strongly suggested that Pax9 may interact with
Tbx1 and its related genes in the morphogenesis of the PAAs, we
therefore looked for a genetic interaction between Tbx1 and Pax9 in
mice. We found that all mice examined (embryos and neonates)
double heterozygous for each gene (i.e. Tbx1+/–;Pax9+/–) displayed
some defect associated with abnormal development of the 4th PAA,
most notably IAA-B. Although hypoplasia or absence of the 4th
PAAs is a feature in mouse embryos heterozygous for Tbx1
(Lindsay et al., 2001), this phenotype was significantly more
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prevalent in Tbx1+/–;Pax9+/– mice, and much higher than observed
in Tbx1+/– embryos. It therefore appears that combining one Pax9-
null allele with one Tbx1-null allele exacerbates the Tbx1+/–
phenotype.
We used our novel Pax9Cre mouse to conditionally delete Tbx1
from the pharyngeal endoderm, while simultaneously creating
double haploinsufficiency for the two genes in this tissue. A highly
significant reduction in the number of Tbx1+/flox;Pax9Cre neonates
Fig. 7. Generation of the Pax9Cremouse. (A) A Pax9Cre targeting vector was created with aCre cassette inserted into the SmaI restriction sites found in exons
2 and 3 of the Pax9 gene. For transformation, the vector was linearised with SfiI. (B) Correctly targeted ES cells were identified by Southern blotting on
XbaI-digested genomic DNA. (C) The derivedPax9Cre-Neomicewere crossed with FLPe-expressingmice to remove the neomycin cassette and createPax9Cre
mice, which were genotyped using the indicated primers. (D-G) Pax9Cre mice were mated with R26RlacZ reporter mice and embryos were stained with
X-Gal at E8.5 (n=3), E9.5 (n=7), E10.5 (n=6) and E11.5 (n=5). Positive staining in regions known to express Pax9 was observed (alb, anterior limb bud; np, nasal
process; pp, pharyngeal pouch; vc, vertebral column). (H-Q) Pax9Cre and Pax9flox/flox mice were crossed to create Pax9+/flox (control) and Pax9Cre/flox (mutant)
mice. All Pax9Cre/flox neonates died on the day of birth and presented with the typical Pax9-null phenotype (n=5), including a bloated abdomen (I, arrow)
and pre-axial digit duplication (d) in the hind limb (K, arrow). Sections of E14.5-E15.5 embryos (n=6) showed cleft palate (CP; M), absent thymus and
cardiovascular defects (O,Q). AoA, aortic arch; BC, brachiocephalic; Th, thymus. Somite counts (s) are indicated. Scale bars: 500 µm.
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born was observed, indicating that heterozygous loss of Tbx1 and
Pax9 from the pharyngeal endoderm has a major impact on
postnatal survival, with almost two-thirds of the recovered neonates
examined having identifiable cardiovascular defects. A similar
proportion of affected mutants was found at foetal stages. Avascular
ring structure was observed in Tbx1+/flox;Pax9Cre mutants
(Fig. 8H), similar to that described in Lgdel/+ mice, which are
chromosomally engineered to be hemizygous for Tbx1 (Merscher
et al., 2001), and also in Six1;Eya1 mutant embryos (Guo et al.,
2011a). Eya1 was significantly reduced in Pax9-null pharyngeal
arch tissue. When embryos were examined at mid-embryogenesis,
however, we found that almost all displayed 4th PAA defects. When
compared with our Tbx1+/–;Pax9+/– embryo data it was apparent
that there was no significant difference in the incidence of bilateral
4th PAA defects between Tbx1+/flox;Pax9Cre and Tbx1+/–;Pax9+/–
embryos. This indicates that the conditional heterozygous deletion
of Tbx1 from the pharyngeal endoderm, in the context of Pax9
heterozygosity, has the same effect on 4th PAA morphogenesis as
seen in the global Tbx1+/–;Pax9+/– embryos at E10.5. Although the
ink injection data from Tbx1+/flox;Pax9Cre embryos matches that
seen in Tbx1+/–;Pax9+/– embryos, and shows that heterozygous loss
of Tbx1 from the pharyngeal endoderm severely affects PAA
morphogenesis, there is a discrepancy in the cardiovascular
phenotype observed at foetal and neonatal stages that does not
reflect that seen at mid-embryogenesis, nor that observed in
Tbx1+/–;Pax9+/– embryos. It is well documented, however, that
the Tbx1+/– 4th PAA phenotype does recover during development
(see Table S6). It therefore appears that a conditional deletion of
Tbx1 from the pharyngeal endoderm in the context of Pax9
haploinsufficiency replicates the Tbx1 heterozygous arch artery
phenotype in terms of a highly penetrant 4th PAA defect at mid-
embryogenesis that partially recovers by the foetal stage. Our data,
Fig. 8. Conditional deletion of Tbx1 from the pharyngeal endoderm. (A) Pax9Cre drives expression of the eYFP reporter gene in the pharyngeal endoderm at
E9.5. Scale bar: 500 µm. (B-D) Flow sorting and qPCR of eYFP-positive and -negative pharyngeal arch cells from Pax9Cre;eYFP control and Tbx1+/flox;Pax9Cre
E9.5 embryos (n=5 of each; dissected as shown in A). From control embryos, the eYFP-positive cells (yellow circles) were significantly enriched for
eYFP (B) and Pax9 (C) compared with eYFP-negative cells (black squares). (D) There was a significant reduction in Tbx1 levels in Tbx1+/flox;Pax9Cre (mutant)
eYFP-positive cells (yellow squares) compared with controls (yellow circles). *P<0.05, **P<0.01 (two-tailed unpaired t-test). (E-J) Cardiovascular defects in
Tbx1+/flox;Pax9Cre mice. (E,F) Neonates were collected shortly after birth and the aortic arch arteries examined. (E) Control neonates (n=39 wild-type, n=43
Pax9Cre and n=33 Tbx1+/flox) all had normal arch arteries. (F) Tbx1+/flox;Pax9Cre mutants (n=8) had cardiovascular defects such as a right-sided aorta
(R-Ao) and A-RSA. Scale bars: 1 mm. (G,H) Embryos at E13.5-E15.5 were analysed by imaging (n=26 mutants). (G) Control embryo with normal cardiovascular
system. (H) In the mutant there is a vascular ring formed by a R-Ao and an A-RSA. Scale bars: 500 µm. (I,J) Embryos collected at E10.5 (36-43 s) were injected
intra-cardially with ink. (I) In Tbx1+/flox control embryos (n=15), PAAs 3-6 were patent to ink. (J) In Tbx1+/flox;Pax9Cre mutant embryos (n=17), the 4th PAA was
frequently absent (asterisk). Somite counts (s) are indicated. Scale bars: 100 µm. Ao, aorta; AD, arterial duct; LCC, left common carotid artery; LSA, left
subclavian artery; LV, left ventricle; RCC, right common carotid artery; RSA, right subclavian artery; RV, right ventricle. The somite numbers given in the legend
reflect the range analysed for the whole study. The figure contains representative images only.
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however, do raise the question of whether we are seeing the effect of
a pharyngeal endoderm-specific loss of Tbx1 with Pax9Cre or a
genetic interaction occurring between Tbx1 and Pax9 in the
pharyngeal endoderm? Conditional deletion experiments have
been performed in transgenic mice to identify the role of Tbx1 in
specific tissues and have examined the effect of Tbx1 heterozygosity
in the pharyngeal mesoderm and/or epithelium for 4th PAA
development (see Table S7). When compared, our data clearly show
that the 4th PAA phenotype is muchmore penetrant than that seen in
embryos only heterozygous for Tbx1 in the pharyngeal epithelia.
We therefore conclude that we are showing a strong genetic and cell-
autonomous interaction between Tbx1 and Pax9 within the
pharyngeal endoderm that impacts on 4th PAA morphogenesis.
Moreover, and in support of a phenotype extending beyond what is
expected from a Tbx1 heterozygous phenotype, our Tbx1flox;
Pax9Cre mice display a high incidence of perinatal lethality, a
feature not previously described in Tbx1+/– mice. Interestingly, the
homozygous deletion of Tbx1 from the pharyngeal endoderm using
Sox17Cre mice resulted in pharyngeal arch aplasia but not in a
common arterial trunk, although IAA was observed (Jackson et al.,
2014). This phenotype is similar to that seen in our Tbx1;Pax9
mutants but is distinct from either Tbx1 and Pax9 constitutive null
mutants.
Pax9 signalling from thepharyngeal endoderm is required for
3rd PAA maintenance
The mammalian PAAs develop symmetrically in a cranial to caudal
sequence, and then subsequently remodel to form the typical
asymmetric aortic arch artery system seen in the adult (Bamforth
et al., 2013; Hiruma et al., 2002). In normal PAA development, the
1st artery forms first, followed by the 2nd, but these two vessels
rapidly remodel and contribute to capillary beds and the mandibular
and hyoid arteries. In some Pax9–/– embryos, these vessels
aberrantly persisted into E10.5 and E11.5, and may contribute to
the anomalous arrangement of the aortic arch arteries when the 3rd
PAAs collapse. In normal development, the 3rd PAAswill form part
of the common and proximal internal carotid arteries, which
elongate as the embryo grows. The carotid duct involutes and the
dorsal aorta anterior to this segment will form the distal internal
carotid artery, with the external carotid artery derived from the
proximal parts of the 1st and 2nd PAA (Hiruma et al., 2002). The
persistence of the 1st and/or 2nd PAAs in Pax9–/– embryos, coupled
with the failure of the 3rd PAAs to be maintained and the carotid
duct to involute, results in the external carotid arteries rising directly
from the aorta, and the internal carotid arteries from the anterior
dorsal aortae. This phenomenon has been described clinically
(Roberts and Gerald, 1978). Although reduced numbers of NCCs
were found in the caudal pharyngeal arches at E10.5, migration,
apoptosis or proliferation of NCCs did not appear to be impaired in
Pax9-null embryos. It is well recognised that NCCs differentiate
into the SMCs that are important for the stabilisation of the
remodelled PAAs (Hutson and Kirby, 2003) and it is likely that the
failure of SMCs to envelop the 3rd PAAs in Pax9-null embryos
results in the collapse of this vessel. This has also been described in
Hoxa3-null embryos (Kameda, 2009) and reduced NCC migration
in genetic mouse and surgical chick models also leads to defects of
the 3rd PAAs (Bradshaw et al., 2009; Epstein et al., 2000; Franz,
1989; Nishibatake et al., 1987). Wewere unable to look for a similar
occurrence in the 4th PAAs, as this fails to form in the majority of
Pax9-null embryos. Signalling between the pharyngeal endoderm
and NCC does occur (Graham et al., 2005) so it is therefore possible
that signals emanating from the pharyngeal endoderm under Pax9
control are necessary to influence the differentiation of NCCs into
SMCs; without these signals, the 3rd PAAs are not supported during
the remodelling phase of arch artery development and they collapse.
The top twoGSEA pathways identified from the RNA-seq datawere
‘extracellular matrix organisation’ and ‘axon guidance’, and these
could be relevant for a NCC-derived phenotype, particularly as the
extracellular matrix is known to be crucial for the migration of
NCCs (Henderson and Copp, 1997; Perris and Perissinotto, 2000)
and the slit, ephrin, semaphorin and plexin genes listed under ‘axon
guidance’ are usually associated with NCC expression or migration
in cardiovascular development (Epstein et al., 2015; Kirby and
Hutson, 2010; Sun et al., 2018). There is, however, an alternative
explanation for the collapse of the 3rd PAAs. Haemodynamic force
plays a major role in artery development (Culver and Dickinson,
2010; Yashiro et al., 2007), so it is possible that the 3rd PAA defect
is a consequence of increased blood flow to the persistent 1st/2nd
PAAs, which prevents sufficient blood flow to the 3rd PAAs,
resulting in impairment of flow-induced arteriogenesis. This may
also be an explanation for the failure of the 4th PAAs to form. A
reduced haemodynamic force would also explain the reduction in
SMC recruitment as this is also dependent on blood flow (Padget
et al., 2019). Although endothelial cells were present within the 4th
pharyngeal arch of Pax9-null embryos, they apparently failed to
condense into tubes, a feature that has also been described in both
Tbx1-null and Gbx2-null embryos (Byrd and Meyers, 2005;
Calmont et al., 2009).
The double outlet right ventricle phenotype observed at E15.5 in
Pax9-null embryos probably arises from the marked outflow tract
rotation defect due to a change in the aortic to pulmonary valve axis
angle (Bostrom and Hutchins, 1988; Lomonico et al., 1986), which
is also observed in Pax3 and Pitx2c mutant hearts (Bajolle et al.,
2006).
In summary, Pax9 expression in the pharyngeal endoderm has
regional (anterior/posterior) roles in regulating the morphogenesis
of the PAAs (Fig. 9). In the 3rd pharyngeal arch, Pax9 is important
for controlling NCC differentiation into the SMCs that support the
remodelling vessel, whereas in the 4th pharyngeal arch endoderm,
the interaction of Pax9 with Tbx1 and its targets is crucial for the
formation of the 4th PAAs.
MATERIALS AND METHODS
Mice
The mice used in this study have previously been described: Pax9+/– (Peters
et al., 1998), Pax9flox (Kist et al., 2007), Tbx+/– (Jerome and Papaioannou,
2001), Tbx1flox (Xu et al., 2004), Wnt1Cre (Danielian et al., 1998),
R26ReYFP (Srinivas et al., 2001), R26RlacZ (Soriano, 1999) and FLPe
(Dymecki, 1996). All mice were maintained on a C57Bl/6J genetic
background. All studies involving animals were performed in accordance
with UK Home Office Animals (Scientific Procedures) Act 1986.
Generation of Pax9Cremice
The Pax9Cre targeting construct was designed to replace a 1.06 kb section
of the Pax9 gene, spanning the second half of exon two, containing the start
codon, and the first half of the 3rd exon, containing the paired box and
octapeptide motif, with a promoterless Cre recombinase gene preceded by a
consensus Kozak sequence, in the pPNT4 targeting vector (Conrad et al.,
2003), using standard molecular biology methods (Fig. 7A). The 1.3 kb
right homology arm, generated as previously described (Kist et al., 2005),
was inserted between the FRT-flanked PGK-Neomycin cassette and the
HSV-Thymidine Kinase cassette of pPNT4. The unwanted loxP site of
pPNT4 was removed by XbaI partial digestion, followed by Klenow
treatment and re-ligation. The left homology arm was generated as a 7.4 kb
SalI to SmaI fragment of the Pax9 genomic region that included exon 1 and
the first half of the second exon, and was inserted 5′ of the Cre recombinase
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gene. The targeting vector was linearized with SfiI and mouse ES cells were
targeted and selected as previously described (Kearns et al., 2013). Southern
blot analysis was performed according to standard methods following XbaI
digest of genomic DNA. An external southern probe was used to verify
integration of the targeting cassette in the 5′ region (Fig. 7B) and PCR was
used to validate integration of the 3′ region (not shown). The FRT-flanked
PGK-neomycin cassette was removed by crossing the derived Pax9Cre-Neo
mice with FLPemice (Dymecki, 1996) to create Pax9Cremice, which were
then backcrossed to strain C57Bl/6J for over six generations. Genotyping by
multiplex PCR [primers: F1-ACTCAAGCCTCTTTCAGCCC (common),
R1-TTGTTCTCACTGAGCCGGCCTGT (Pax9 exon 2) and R2-GTTGC-
ATCGACCGGTAATGC (Cre)] were used to simultaneously identify the
wild-type and Pax9Cre alleles (Fig. 7C).
Breeding
Male and female mice were mated and the detection of a vaginal plug the
next morning considered to be E0.5. Pregnant females were culled on the
required day and embryos collected. Embryos at E9.5-E11.5 were staged by
somite counting.
Imaging
Magnetic resonance imaging (MRI) was performed using a 9.4T MR system
(Varian, US) as previously described (Bamforth et al., 2012; Schneider et al.,
2004) on embryos at E15.5. High Resolution EpiscopicMicroscopy (HREM)
and micro-computed tomography (µCT) techniques have been described in
detail elsewhere (Degenhardt et al., 2010;Geyer et al., 2009).AllMRI,HREM
and µCT images were converted into a volume dataset and segmented using
Amira software (Thermo Fisher Scientific) to create 2- and 3-dimensional
(3D) images. Structures were manually outlined using the label field function
of Amira and surface rendered to produce the 3D images. Intra-cardiac ink
injections were performed as described previously (Calmont et al., 2009).
Aorta measurements were taken from the region just proximal to the point at
which the ascending aorta becomes the aortic arch. Haematoxylin and Eosin
staining, X-gal staining and Pax9 whole-mount in situ hybridisation were
performed using standard techniques. mRNA expression on sections was
examined by in situ hybridisation using RNAscope Multiplex Fluorescent v2
Assay (AdvancedCellDiagnostics) following themanufacturer’s instructions.
Probe details given in Table S8. For proliferation assays, BrdU (Sigma-
Aldrich) dissolved in PBS was administered by intraperitoneal injection
at a dose of 50 mg/kg to pregnant dams 1 h before embryo collection.
Immunohistochemistry was performed using standard techniques (antibody
details are in Table S8) on paraformaldehyde-fixed embryo sections and
fluorescently imaged on an Axioimager (Zeiss). To assess an apoptotic index
within the pharyngeal arches, control and Pax9–/– embryos at E9.5 (n=3
per genotype; 24-28 somites) and E10.5 (n=3 per genotype; 30-35
somites) were examined following immunostaining with the anti-caspase
3 antibody. To assess a proliferative index within the NCC in the
pharyngeal arches, control and Pax9–/– embryos expressing Wnt1Cre
activated eYFP at E9.5 (n=3 per genotype; 23-28 somites) and E10.5
(n≥4 for each genotype; 31-39 somites) were examined following
immunostaining using anti-BrdU and anti-GFP antibodies. All positively
stained and DAPI-positive cells within the pharyngeal arches were
counted and the ratio of positively stained cells over the total number of
cells calculated. The average number of NCCs within the caudal
pharyngeal arches was calculated at E9.5 (n=3 per genotype, 23-28
somites) and E10.5 (n=4 per genotype, 32-34 somites). For all cell
counting experiments, at least three sections per embryo were assessed.
Transcriptome analysis
Wild-type (Pax9+/+) and Pax9-null (Pax9−/−) embryos at E9.5 (n=3 of each
genotype, stage-matched for 26-27 somites) were collected in ice-cold
DEPC-PBS and the pharyngeal region, from the junction between the first
and second pharyngeal arch to the base of the heart, was dissected free in
RNAlater (Sigma-Aldrich). Genotypes were identified by PCR from the
embryo tails and/or yolk sac material. Total RNA was extracted using the
QIAGEN Plus Micro kit with genomic DNA Eliminator columns, and total
RNA eluted in 30 μl RNase-free water. RNA concentration and purity were
assessed by NanoDrop spectrophotometry and Agilent Bioanalyzer with all
samples producing a RIN of 10. Genomic DNA contamination was
excluded by PCR for intronic regions (sensitivity 5 pg/μl). To confirm that
the correct genotypes were processed, cDNA was made from 100 ng total
RNA and a qPCR for Pax9 performed (Fig. 5B). The total RNA samples
were shipped on dry-ice to EMBLM-GeneCore for RNA-seq first-strand
specific library preparation using Illumina TruSeq, and 100 bp paired end
reads were generated from an Illumina HiSeq 2000 Sequencer. Quality
control by FastQC suggested a small amount of adaptor contamination in
each sample, so raw reads were trimmed of adaptor sequence with
Trimmomatic (Bolger et al., 2014). Reads shorter than 36 bp after trimming
were discarded, and reads whose pair had been discarded were also
removed. Trimmed reads were further filtered to keep only uniquely aligned
and non-redundant reads to remove a vast majority of pseudogenes caused
by multi-mapping. In addition, to avoid bias due to imbalanced library sizes
among conditions, all samples were sub-sampled towards the smallest
sample (mt-663_1). The resulting reads were aligned to the Mouse Genome
(Ensembl release 81, GRCm38) using the splice aware read aligner STAR 2
(star-2.5.2a-0, 20/01/2017) (Dobin et al., 2013). Finally, aligned reads were
assigned to Ensembl genes using featureCounts (Liao et al., 2014) with
default parameters. These count tables were imported into R and analysed
using the package LIMMA (Ritchie et al., 2015) and voom function from
Bioconductor (Gentleman et al., 2004). A gene set enrichment analysis tool
(Subramanian et al., 2005) was used to predict signalling pathways that were
Fig. 9. Proposed model for role of Pax9-mediated signalling during
pharyngeal arch artery development. (A) In wild-type embryos, Pax9
expression in the 3rd pharyngeal arch endoderm induces neural crest cells
(NCCs), either directly or indirectly, to differentiate into the SMCs that form
around the endothelium of the remodelling 3rd PAAs. In the 4th arch
endoderm, Tbx1 and Pax9 function together to, most likely indirectly, control
formation of the 4th PAAs, potentially through collaboration with Chd7 and
Gbx2. (B) In Pax9-deficient embryos, signals from the 3rd pharyngeal arch
endoderm are compromised and NCC differentiation into SMCs is impaired,
resulting in the collapse of the 3rd PAAs by E11.5. In Tbx1-Pax9 double
heterozygous embryos, reduced levels of Tbx1 andPax9 in the 4th pharyngeal
arch endoderm are insufficient to allow the 4th PAAs to form.
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affected when gene expression in the wild-type and the Pax9 mutant
samples was compared. All resulting pathways were filtered for a
familywise-error rate (P<0.001) to correct for multiple hypotheses testing.
Flow cytometry
The pharyngeal arch region of E9.5 Pax9Cre;eYFP control (n=5; 23-27
somites) and mutant Tbx1+/flox;Pax9Cre;eYFP (n=5; 24-29 somites)
embryos was dissected free as described above and dissociated to single
cells with Accumax (eBioscience) by incubating at 37°C for 30 min. The
reaction was stopped by the addition of 10% foetal calf serum (FCS), and
cells were washed in PBS and resuspended in 10% FCS. Cells were stained
with propidium iodide. Fluorescence-activated cell sorting was performed
on a Becton Dickinson FACS Aria II using a 100 µm nozzle and a sheath
pressure of 20 psi. Single cells were gated using FSC-A versus SSC-A
followed by FSC-Aversus FSC-H and FSC-Aversus SSC-W to remove any
doublets. Live single cells were gated using propidium iodide versus FSC-
A, and this population was finally gated on eYFP-positive and -negative
cells and sorted into collection tubes.
Quantitative real-time RT-PCR (qPCR)
RNA, from either dissociated pharyngeal arch cells or flow-sorted cells, was
extracted using Trizol reagent (Invitrogen) combined with a Purelink RNA
Mini Kit (Ambion) and on-columnDNase1 treatment. RNAwas eluted with
30 µl RNase-free water. Total RNA was converted to cDNA using a High-
Capacity cDNAReverse transcription kit (Applied Biosystems) and random
hexamers. qPCR was performed using SYBR Green JumpStart Taq
ReadyMix (Sigma-Aldrich) using the primers listed in Table S9. All
qPCR reactions were performed in triplicate on a QuantStudio 7 Real-Time
PCR System (Thermo Fisher Scientific). Data were analysed using the
comparative Ct method (Schmittgen and Livak, 2008).
Statistical analysis
A chi-squared test was used to compare genotype frequencies of litters, and
Pearson’s chi-squared test for associations was used to compare defect
frequencies between the different genotypes. For analysis of qPCR data,
aorta measurements and cell counts, datasets were tested for variance using
the Shapiro-Wilk test (Prism 8.01 software, GraphPad). Two-tailed unpaired
t-tests were performed on normally distributed data, and a two-tailed Mann–
Whitney U non-parametric test was used for not normally distributed data.
One-way ANOVA with Tukey’s multiple comparison test was used to
analyse qPCR data from four embryo genotypes. A hypergeometric
distribution test was used to calculate a P-value for observing an overlap
between two gene lists in R. Groups were considered significantly different
when P<0.05 or P≤0.1 for RNA-seq data. No statistical methods were used
to predetermine sample size, which were chosen based on previous
experience to obtain statistical significance and reproducibility. No data
points were excluded and all data collected from each individual experiment
were used for analysis.
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Supplementary Figures 
Figure S1. Pax9 expression during mouse pharyngeal development. A – C, coronal, 
and D – F, transverse sections of embryos at E9.5 (A), E10.5 (B), E11.5 (C, D), E12.5 (E) 
and E15.5 (F). Pharyngeal arch arteries (paa) are outlined. Pax9 is expressed in the 
pharyngeal endoderm at E9.5 and E10.5, and is subsequently expressed within the 
esophagus (es), developing thymus (th) and ultimobranchial bodies (ub) of the pharyngeal 
region. Somite counts (s) indicated. Abbreviations: L/R-4th, left/right 4th pharyngeal arch 
artery; lcc, left common carotid; oft, outflow tract; pa, pharyngeal arch; pp, pharyngeal 
pouch; ph, pharynx; rcc, right common carotid; tr, trachea. Scale, 100μm.  
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Figure S2. Pax9 mRNA is reduced in the pharyngeal region of Tbx1–/– embryos. Whole-
mount in situ hybridization using a Pax9 riboprobe demonstrates that Pax9 is specifically 
expressed in the pharyngeal endoderm and somites at E9.5 in wild-type (A) and Tbx1+/– (B) 
embryos. C, In Tbx1–/– embryos, however, Pax9 levels are dramatically reduced from the 
pharyngeal endoderm (arrow). Somite counts (s) indicated. Scale: A – C, 500μm; A’ – C’, 
100μm. 
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Figure S3. Relationship between shared genes differentially expressed in Tbx1-null 
and Pax9-null datasets. Shared genes (n=329) between the Tbx1-null and Pax9-null 
datasets were compared to see if they were concordant (i.e. genes went up in both datasets, 
or down), or if they were discordant (i.e. went up in one dataset but down in the other). This 
revealed that 35% of shared genes were both down, but also 63% of shared genes were 
down in Tbx1-nulls and up in Pax9-nulls. Examples of genes in each category are shown in 
the Table. 
Gene up or 
down per 
dataset 
Concordant Discordant 
Tbx1 up, 
Pax9 up 
Tbx1 down, 
Pax9 down 
Tbx1 up, 
Pax9 down 
Tbx1 down, 
Pax9 up 
n 2 114 7 207 
Examples of 
genes in each 
category 
Cisd2, 
CxCl13 
Aldh1a1, 
Gbx2, Gli3, 
Myh9, Notch3, 
Pax9, Pbx1, 
Tbx1 
Col3a1, 
Col6a1, 
Kif1b, 
Sparcl1, Vtn 
Bmp5, Bnip3, 
Cdkn1b, 
Cldn12, Dlx6, 
Fgfr1op2, 
Hes1 
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Figure S4. Thymus abnormalities are seen in Tbx1;Pax9 mutant embryos. 
An abnormally placed thymus was frequently observed in conjunction with arch artery 
defects. A, Normally placed thymic lobes (purple) in a wild-type control embryo. The thymic 
lobes are placed ventrally to the aortic arch arteries. B, C, In a Tbx1+/–;Pax9+/– mutant 
embryo (B) and a Tbx1+/–;Pax9Cre mutant embryo (C), both with interrupted aortic arch and 
aberrant right subclavian artery (A-RSA), the thymic lobes are split and asymmetrically 
placed. The right and left common carotid arteries can be seen traversing between the two 
thymic lobes. Abbreviations: LCC, left common carotid; LSA, left subclavian artery; RCC, 
right common carotid; Th, thymus. Scale, 500µm. 
Figure S5. Reporter gene expression from the Pax9Cre allele.  
A, B, Cre mediated recombination of lacZ by Pax9Cre induces expression in the pharyngeal 
endoderm at E9.5. Scale, 500 µm. 
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Supplementary Tables 
Table S1 (Excel file). Differentially expressed genes (p≤0.1) from RNA-seq analysis of 
Pax9-null pharyngeal arch tissue. Sheet A, B, The top up- and down-regulated coding 
genes from the Pax9 RNA-seq data are listed and ranked by log2 fold-change, with a cut off 
-0.59 for the down-regulated genes (A; n=647) and 0.59 for the up-regulated genes (B; 
n=240).  
Sheet C, D, Values of the Tbx1-Pax9 shared genes from the Pax9 RNA-seq data, ranked by 
fold-change. C, Genes down-regulated in Pax9-null pharyngeal arch tissue (n=122). D, 
Genes up-regulated in Pax9-null pharyngeal arch tissue (n=220). 
Table S2. Genotypes of weaned pups (at 3 weeks of age), neonates (collected within 24 h of 
birth) and embryos (E15.5 and E9.5) from a Tbx1+/– and Pax9+/– cross. There was a 
significant loss of expected pups at weaning (Chi-squared test; **** p=1.4x10-12). There was 
no significant difference from the expected number of pups for each possible genotype in 
neonates or embryos.  
Genotype Weaning Neonate E15.5 E9.5 
Wild-type 55 7 16 20 
Pax9+/– 68 10 15 14 
Tbx1+/– 43 6 19 17 
Tbx1+/–;Pax9+/– 2 **** 9 20 23 
Total 168 32 70 74 
n expected for 
each genotype 42 8.0 17.5 18.5 
Table S3. Summary of thymus phenotypes observed in Tbx1 and Tbx1;Pax9 mutant 
embryos. The thymus was frequently seen to be asymmetric in appearance and split apart 
in Tbx1+/–;Pax9+/– and Tbx1+/flox;Pax9Cre mutants. An abnormal thymus was always 
associated with an arch artery defect. One Tbx1+/–;Pax9+/– mutant presented with an absent 
thymus and an unusual holoprosencephaly type phenotype (not shown). 
Genotype Stage n 
Thymus phenotype 
Normal Split & asymmetric Absent
Tbx1+/– 
E15.5 
19 15 (79%) 
4 
(21%) 0 
Tbx1+/–;Pax9+/– 20 3 (15%) 
16 
(80%) 
1 
(5%) 
Tbx1+/flox;Pax9Cre E13.5 -E15.5 26 16 (61.5%) 
10 
(38.5%) 0 
Click here to Download Table S1
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Table S4. Genotypes of neonates (collected within 48 h of birth) from a Tbx1+/flox x Pax9Cre 
cross. Foetuses (E13.5 – E15.5) and embryos (E10.5) were from a Tbx1flox/flox x Pax9Cre 
cross. There was a significant loss of expected neonates (Chi-squared test; **** p=2.4x10-5). 
Genotype Neonate Foetus Embryo 
Wild-type 39 - - 
Pax9Cre 43 - - 
Tbx1+/flox 33 18 15 
Tbx1+/flox;Pax9Cre 8**** 17 17 
Total 123 35 32 
n expected for 
each genotype 30.75 17.5 16 
Table S5. PAX9 mutations and aberrant expression levels that have been associated with 
human disease.  
Disease Mutation/ karyotype Detail Other Reference 
Congenital 
Heart 
Defect 
14q13 
(105kb deletion) 
IAA-B, BAV, hypoplastic aorta, 
VSD 
Facial 
dysmorphisms 
1
46,XY,del(14) 
(11.2q13) Persistent foramen ovale 
Craniofacial 
defects 
2
46,XY,del(14) 
(11.2q13) 
Patent foramen ovale and 
patent ductus arteriosus 
Craniofacial 
defects, delayed 
bone ossification 
3
14q13.3 
(884kb deletion) 
Persistent pulmonary 
hypertension of the newborn 
Oligodontia, 
hypothyroidism 
4
Craniofacial PAX9 mutations 
Hypo/oligodontia - 5,6
Cleft lip/palate Hypodontia 7,8
Skeletal 
46,XY,t(14;18) 
(q13;q12) Mesomelic bone dysplasia - 
9
Jarcho-Levin 
Syndrome Vertebral segmentation defect 
Reduction in PAX9 
expression 
10
Cancer 14q13.3 Lung cancer PAX9 expression amplified 
11
PAX9 is located at 14q13.3. 
Abbreviations: BAV, bicuspid aortic valve; IAA-B, interrupted aortic arch type B; VSD, ventricular 
septal defect. 
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Table S6. Penetrance of 4th PAA defects in Tbx1+/– and Tbx1+/flox;Pax9Cre mutant embryos 
assessed from published and our data. 
Genotype Stage n % defects a Reference 
Tbx1+/– 
E10.5–E11.0 127 87% (63-100%) 12-17 & this study 
E11.5 76 62% (50-74%) 16-18
Fetal (E14.5–P2) 215 34% (18-49%) 12-16,18-20 & this study 
Tbx1+/flox; 
Pax9Cre 
E10.5 17 92% This study 
Fetal (E13.5–E15.5) 18 33% This study 
a For Tbx1+/– mice, % defects are given as the mean incidence of abnormalities for the studies cited, 
with 95% confidence intervals. 
Table S7. Penetrance of 4th PAA defects following heterozygous deletion of Tbx1 (globally 
or conditionally) from E10.5 embryos and assessed by intra-cardiac ink injection from 
published and our data. 
Genotype Tissue affected n Abnormal Reference 
Tbx1+/– Endoderm, mesoderm, ectoderm 127 87% 
12-17 & this study 
Tbx1+/–; 
Pax9+/– 
Endoderm, mesoderm, 
ectoderm 9 100% This study 
Tbx1+/flox; 
Pax9Cre Endoderm 17 92% This study 
Tbx1+/flox; 
Foxg1Cre Endoderm* 30 0 
21
Tbx1+/flox; 
Mesp1Cre Mesoderm 19 0 
22
Tbx1+/flox; 
Foxg1Cre 
Endoderm, mesoderm, 
ectoderm 21 42% 
22
Tbx1+/flox; 
Fgf15Cre Endoderm, ectoderm 34 20% 
22
Tbx1+/flox; 
Hoxa3Cre 
Endoderm, mesoderm, 
ectoderm 
(neural crest) 
17 50% 22
Tbx1+/flox; 
AP2aCre** 
Ectoderm 
(neural crest) 9 0 
14
* Mice were maintained congenic in the Swiss Webster background to restrict Cre
expression to the pharyngeal endoderm. 
** Tbx1+/flox;AP2aCre phenotype assessed at E15.5 by histology. 
N.B. Tbx1 is not expressed in neural crest cells. 
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Table S8. Antibodies and probes used for immunostaining and in situ hybridisation. 
Target Catalogue number Species and type Supplier Dilution 
Primary antibodies 
Pax9 ab28538 Rat monoclonal 
Abcam 
1:100 
Tbx1 ab18530 Rabbit polyclonal 1:100 
CD31 ab56299 Rat monoclonal 1:100 
GFP ab6556 Rabbit polyclonal 1:100 
ERG ab92513 Rabbit monoclonal 1:1000 
BrDU ab6326 Rat monoclonal 1:200 
Cleaved caspase-3 9661 Rabbit polyclonal Cell Signalling 1:300 
aSMA a2547 Mouse monoclonal Sigma 1:200 
Secondary antibodies 
Donkey anti-mouse 
IgG Alexa Fluor 488 A-21202 - 
Thermo Fisher 
Scientific 1:200 
Donkey anti-rabbit 
IgG Alexa Fluor 488 A-21206 - 
Donkey anti-rabbit 
IgG Alexa Fluor 594 A-21207 - 
Donkey anti-rat IgG 
Alexa Fluor 488 A-21208 - 
Donkey anti-rat IgG 
Alexa Fluor 594 A-21209 - 
Goat anti-rat IgG 
Alexa Fluor 647 A-21247 - 
Nuclear stain 
DAPI H-1200 - Vector Laboratories - 
RNAscope probes 
Pax9 454321-C2 
Mouse Advanced Cell Diagnostics 
1:50 
Tbx1 481911 Direct 
Chd7 458031 Direct 
Gbx2 314358 1:50 
Table S9. qPCR primer sequences 
Gene RefSeq Primer sequence 
Chd7 NM_001081417 GGAGAACCCTGAGTTTGCTG CCCTGAAGTAGAGGCGACAG
eYFP - ACGTAAACGGCCACAAGTTC TCGTCCTTGAAGAAGATGGTG
Gapdh NM_008084 TGTGCAGTGCCAGCCTCGTC TGACCAGGCGCCCAATACGG
Gbx2 NM_010262 GAGGCGGCAACTTCGACAAAGCC TCCTCCTTGCCCTTCGGGTCATC
Pax9 NM_011041 CCGGCACAGACTTCCTTTTA CCTTCCGTTCACGAACACTC
Tbx1 NM_011532 TGAGGAGACACGCTTCACTG CTGCAGCGTCTTTGTCTGAG
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